PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
16-May-2023 Bloomsbury Genetic Therapies Announces Clinical Trial Application Accepted by U.K. Regulatory Agency to Initiate Phase 1/2 Gene Therapy Trial of BGT-OTCD for the Treatment of Ornithine Transcarbamylase Deficiency (OTCD) Bloomsbury Genetic Therapies
16-May-2023 TILT Biotherapeutics Announces First Patient Dosed in Phase I Solid Tumors Trial Assessing Oncolytic Adenovirus TILT-123 in Combination with Checkpoint Inhibitor TILT Biotherapeutics
16-May-2023 Emerging Trends in Single Use Bioprocessing: Advancements and Market Opportunities Markets and Markets
16-May-2023 Alfa Chemistry: Lithium-Ion Battery Testing Contributes to Enhanced Battery Performance Alfa Chemistry
16-May-2023 New Partnership Established: Alfa Chemistry Adds 200,000+ Chemicals to Spaya Database Alfa Chemistry
15-May-2023 OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension OMass Therapeutics
15-May-2023 ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead ELRIG UK
12-May-2023 Veranova Appoints Mike Riley as Chief Executive Officer Veranova
12-May-2023 Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer Pan Cancer T
11-May-2023 BioInnovation Institute appointed by the Danish government to run international deep tech start-up accelerator to unlock the potential in quantum science BioInnovation Institute
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
09-May-2023 Transgene’s Combined General Meeting of May 5, 2023 Transgene
09-May-2023 Press Release: IVDR certificate SphingoTec GmbH
08-May-2023 Omnix Medical Announces Excellent Topline Data from the Phase I Clinical Trial of its Novel Anti-Infective OMN6 Omnix Medical
06-May-2023 New Alternative Energy Materials and Pheromone Ingredients Available from Alfa Chemistry Alfa Chemistry
04-May-2023 Endogena Therapeutics Completes Enrollment Ahead of Schedule in its Phase 1/2a Trial of EA-2353 for Retinitis Pigmentosa Endogena Therapeutics
04-May-2023 BioSenic identifies key biomarkers for cGvHD and submits patent to EPO BioSenic
04-May-2023 Danish Startups Pursue US Expansion Opportunities Through TMC BioBridge Texas Medical Center (TMC):
04-May-2023 TriApex Completes Series C with Hundreds of Millions of CNY, Led by Legend Capital Legend Capital